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Present knowledge on regulation of fibroblast growth 
is based on in vitro culture of fibroblasts from different 
sources. The research has focused on 2 problems: iden-
tification of the signal that reaches the fibroblast from 
outside and tells it to grow and identification of the 
metabolic reactions inside the cell that commit it to 
initiate DNA synthesis after the signal arrives. Although 
the signal and the metabolic reactions have not yet been 
clearly identified, and the relationship between in vivo 
conditions and the result of these in vitro studies still 
has to be determined, the large body of data collected so 
far and the steadily growing information concerning 
these problems suggest a complex interrelation between 
cellular environment and metabolic processes involved 
in growth regulation. 
Our knowledge of growth regulation of fibroblasts derives 
more from interest in growth regulation of vertebrate cells in 
general than from special interests in fibroblasts. One has to 
keep this fact in mind because some questions of special interest 
to dermatologists have not been asked by investigators with a 
broader interest in general growth regulation. 
Investigators have chosen to work with fibroblasts because 
the cells are readily available for tissue culture and grow easily 
and preferentially from explants or digests of most tissues and 
organs. Fibroblasts grow relatively fast and can be harvested in 
large quan"tities. Continuous cell lines can be established from 
the explanted cultures, and they can be transformed by carcin-
ogens or tumor viruses in vitro for use in studying the properties 
of tumor cells. 
The following discussion presents an overview of results 
obtained from tissue studies of cultures of "normal" fibroblasts. 
Although in some cultures, such as those from embryonic 
sources, the cells may have a different mesodermal origin, such 
as chondroblasts or osteoblasts, it is accepted by most cell 
biologists that the cells used in the investigations described 
below are fibroblasts. 
FIBROBLASTS IN CULTURE 
The cells normally are taken from human biopsy specimens 
or from chicken, mouse, rat, or hamster embryos. Fibroblasts 
derived from biopsies have only a limited in vitro life span; it 
varies from approximately 20 to 60 doublings according to the 
age of the donor [1]. Studies with such cultures can be carried 
out for several passages before the cells are no longer suitable 
for growth in tissue culture; sometimes one can select from 
these cultures cell lines that can be propagated indefinitely. 
One such continuous line in wide use is the 3T3 cell line 
established by Todaro and Green [2] from mouse embryonic 
fibroblasts. 
When normal untransformed fibroblasts are transferred to 
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plates, usually in a defined nutrient medium supplemented with 
serum, they grow logarithmically until they reach their satu-
ration density, which is determined by the cell type, culture 
medium, and serum concentration. Often culture conditions are 
such that cells stop growing soon after they reach confluency. 
Early observations of cessation of cell growth as cells reached 
confluency prompted investigators to suggest that cell-to-cell 
contacts are the signal that halts growth. Vogt and Rubin 
introduced the term "contact inhibition" of growth for this 
phenomenon [3]. However, initial plating of the cells in higher 
concentrations of serum resulted in growth to higher cell dens-
ities [4]. The conclusion that the authors have drawn from this 
fact is that the observed growth arrest is due to the availability 
of growth factors in the culture medium and the availability of 
surface area rather than to establishment of contacts between 
cells. We now prefer to use the term "density-dependent regu-
lation" of growth instead of "contact inhibition" to describe this 
phenomenon. 
Arrest can also be achieved by a change from medium with 
serum to medium without serum. The arrested cells are usually 
in the GI(GO) stage of the cell cycle (Fig 1). Growth of the cells 
can be initiated by the addition of serum to the medium; growth 
then will proceed through the cell cycle in a relatively synchro-
nous fashion (Fig 2). Ten to 15 hr after the addition of serum, 
DNA synthesis begins; mitosis occurs from 24 to 30 hr after 
serum addition. The amount of time required to enter the S 
phase varies somewhat from one cell type to another. In cul-
tures stimulated in the resting phase, the GI(GO) period is 
usually greatly elongated compared to logarithmically growing 
cells. Virally or chemically transformed fibroblasts usually do 
not stop growing under normal culture conditions, have a much 
lower serum requirement, and may become arrested throughout 
the cell cycle. 
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Since normal untransformed fibroblasts in culture seem to 
show the same behavior as their counterparts in vivo, i.e., they 
remain in GI(GO) when they are in a nonproliferating state, 
research has focused mainly on the following questions: "What 
are the factors stimulating the cells to grow?" "What are the 
early events that take place inside the cell after it has received 
the signal to grow?" and "Which of these events commit the 
cell to synthesize DNA 10 to 15 hI' later?" 
GROWTH FACTORS 
Several groups have partially purified or isolated growth-
stimulating activities from serum or tissue. Some of the growth 
factors, e.g., insulin, were already known to have activity not 
related to growth. A list of growth factors for stimulating normal 
fibroblasts arrested in GI (Go) is given in the Table. Of the last 
5 substances in the table, hydrocortisone may be especially 
interesting to clinicians who frequently use this substance to 
stop the growth of fibroblasts and other cells. Growth stimula-
tion of fibroblasts by hydrocortisone fust reported by Thrash 
and Cunningham [34], may not occur in all fibroblasts in 
culture; some groups have found that it is not active alone but 
rather potentiates the effect of other growth factors [20]. 
The factors listed in the Table do not produce as great a 
stimulatory activity as serum when added to cultures whose 
growth was arrested in GI. A background of serum, usually 0.1 
to 0.5%, which by itself is not stimulatory, has been used for 
optimal stimulation with purified growth factors and for main-
tenance of quiescent cultures in a healthy state. It is apparent 
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FIG 1. Analyses, obtained with a Los Alamos design flow microfluo-
rometer, showing DNA content per cell in: (left) a rapidly growing 3T3 
cell population with approximately 40% of the cells in S phase and 
(right) a quiescent 3T3 cell population in which almost all of the cells 
have the G , content of DNA. Graphic estimations of the percentages of 
cells in G" S, and G2 + M were based on the height of the curve in the 
middle of S, as is illustrated by the brollen line in the analysis of the 
growing cell population. 
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FIG 2. Time course of init iation of DNA synthesis, shown by auto-
radiography (radioactive thymidine incorporation from time zero), in 
sparse quiescent 3T3 cells after the addition of: 0 , 4 % serum; 6 , 1% 
serum. The controls (0) remained in 0.2% serum. 
that some of the growth factors are much more active in certain 
combinations than individually. With a low background of 
serum and the appropriate combinat ions of factors, stimulation 
nearly equivalent to that achieved by the addition of fresh 
serum can be obtained. An example of this is the stimulation of 
3T3 cells by fibroblast growth factor (FGF), insulin, dexameth-
asone, and an ammonium sulfate fraction from serum (Fig 3) 
[20]. 
EPIDERMAL GROWTH FACTOR 
A growth factor of polypeptide nature is generally thought to 
exert its init ial effect on the cell by interacting with the cell 
surface, specifically by binding to a receptor on the cell mem-
brane. Several groups have investigated the binding of peptide 
hormones, especially insulin, to the cell surface. However, in 
mammalian cells the level of growth activity produced with 
insulin is rather low, and it seems that its role is more of a 
supporting one for other growth factors. Because purified epi-
dermal growth factor (EGF) is active not only on epidermal 
tissue but also on cultured human fibroblasts [6] and because 
it is available in '25I-Iabeled form, it has been used in the study 
of the biochemical events involved in the binding of a polypep-
tide growth factor to cultured fibroblasts. 
EGF was first isolated from extracts of the male mouse 
submaxillary gland in 1962 and described by Cohen [38]. Its 
biological activity was assayed by precocious opening of the 
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Factors stimulating growth in cultures of resting fibrob lasts 
Factor Cells Refere nce 
FGF 3T3 Gospodarowicz, 1974 [5] 
EGF 3T3 Armelin, 1973 [6] 
Somatomedin B Fibroblasts of Hall et ai, 1975 [7] 
various 
sow'ces 
Somatomedin C Chick embryo Van Wyk et al, 1975 [8] 
fib roblasts 
NSILA Chick embryo Morell & Froesch, 1973 
fibrob lasts [9]; Smith & Temin, 
1974 [10] 
S1 and S2 Rat embryonic Hoffmann et ai, 1973 [11] 
fibroblasts 
Fibroblast WI-38, GWF Houck & Cheng, 1973 [1 2] 
mitogen (human 
fibroblasts) 
Serum factors Human lung Michl & Rezacova, 1966 
fibroblasts [13] 
3T3 Todaro et ai, 1967 [14]; 
Holley & Kiernan, 1968 
[15]; Paul et al, 1971 
[16] 
Mouse Healy & Parker, 1970 [17] 
embryonic 
fibroblasts 
Insulin Chick embryo Temin, 1967 [18] 
fibrobl asts 
3T 3 Yamell & Schnebli, 1974 
[19]; Holley & Kiernan, 
1974 [20] 
Blood platelets 3T3 Kohler & Lipton, 1974 
[21]; Antoniades et ai, 
1975 [22] 
Growth factor 3T 3 Klagsburn et ai , 1977 [23] 
from cartilage 
MSA Chick embryo Pierson & T emin, 1972 
fibroblats [24] 
Factors released BHK S hodell, 1972 [25] 
by cells 
Chick embryo Dulak & Temin, 1973 [26] 
fibroblasts 
3T3 Smith & T emin, 1974 [10] 
BUJ"k, 1976 [27] 
Thrombin Chick embryo Lan Bo Chen & 
fibroblasts Buchanan, 1975 [28] 
Proteolytic 3T 3 Burger, 1970 [29] 
enzymes 
Chick embryo Sefton & Rubin, 1970 [3] 
fibroblasts 
Prostaglandin Rat embryonic Frank et ai, 1973 [31] 
F2n fibroblasts 
3T3 J imenez de Asua et al, 
1975 [32] 
Putrescine Human Pohjanpelto & Raina, 
fibroblasts 1972 [33] 
Glucocorticoids 3T 3 Thrash & Cunningham, 
1973 [34] 
Human Cunningham et ai, 1974 
fibroblasts [35] 
cGMP 3T3 Seifert & Rudland, 1974 
[36] 
PMA 3T3 Sivak, 1972 [37] 
Abbreviations: NSILA = nonsuppressible insulin-like activity; GWF 
= human cutaneous fibroblasts; MSA = Mul tiplication stimulating 
activity; PMA = phorbol myristate acetate. 
eyelids and eruption of the incisors in newborn mice. Human 
EGF was recently isolated from the urine of pregnant women 
[39]. 
The biological properties of human EGF have been examined 
by Carpenter and Cohen [40]. They found that EGF is active 
in extremely low concentrations. It binds rapidly and reversibly 
to specific binding sites on the human fibroblast cell membrane. 
The concentration required for maximal binding (1.5-2 X 10- 9 
M) is 4 times greater than that required for maximal stimulation 
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FIG 3. Initiation of DNA synthesis by known factors . The figure gives 
the percentage replacement of 4% calf serum achieved by: e, insulin, 
either alone or with added dexamethasone (Dx) and/or heated am-
monium sul fate fraction (AS) of mouse serum; ., varying concentra-
tions of FGF alone; 0 , varying concentrations of FGF plus 0.4 /Lg/ml of 
dexamethasone; /';, FGF plus 50 ng/ml of insulin plus 0.4 /Lg/ml of 
dexamethasone; 0, FGF plus 50 ng/ml of insulin plus 0.4 /Lg/ml of 
dexamethasone plus 0.2 mg/ ml of protein from the heated (10 min at 
100°C) 50 to 70% ammonium sulfate fraction of mouse serum. 
of DNA synthesis in quiescent cultures (3.7 X 10- 10 M). Only 
about 25% of the binding sites need to be occupied in order for 
cells whose growth was arrested in G 1 to enter the S phase. 
After binding of EGF to the cells, it is rapidly internalized and 
degraded. As the bound EGF is internalized, most of the mem-
brane receptors become inaccessible to added fresh hormone 
and remain inaccessible for several hours in the continued 
presence of nanogram quantities of the hormone. Maximal 
binding is achieved approximately 40 min after addition of the 
hormone to the medium, and degradation of the hormone 
bound at that time is nearly complete 2 hr later. However, the 
initial binding and subsequent degradation of the bound hor-
mone are not sufficient to stimulate DNA synthesis; the hor-
mone must remain in the culture medium for several hours and 
presumably bind repeatedly to receptors in order to stimulate 
DNA synthesis. Any explanation of the relationship between 
binding of the hormone to the cells and the initiation of DNA 
synthesis has to take into account this time differential between 
initial binding and initiation [40). 
The role of serum or polypeptide hormones such as EGF in 
density-dependent regulation can be studied experimentally. 
The saturation density of the fibroblast culture is proportional 
to the serum or growth factor concentration. The higher the 
original saturation density, the higher the serum or growth 
factor concentration must be raised in order to initiate DNA 
synthesis. The dependence on growth factors can be studied at 
different cell densities in different dishes and at different den-
sities in the same dish. An example of the latter type of 
experimental situation is referred to as "wound healing." 
"WOUND HEALING" 
"Wound healing" experiments provide some of the best ex-
amples of "density-dependent regulation." After a culture has 
become quiescent, a narrow strip of cells is scraped off the dish 
leaving a wound in the monolayer. The medium and concentra-
tion of serum factors remain unperturbed. Cells at the edge of 
the wound then migrate into it and divide (Fig 4). Growth stops 
when the wound reaches the same cell density as the surround-
ing monolayer. The cells in the surrounding layer remain quies-
cent in the same medium in which the cells at the wound edge 
and within the wound divide. 
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FIG 4. Autoradiography of a "wound healing" experiment with 3T3 
cells. Twenty-four hours after "wounding" of the monolayer, "H-thy-
midine was added for a period of 24 hI'; the cells were then prepared for 
autoradiography. The autoradiogramm was kindly provided by Dr. 
Renato Dulbecco, The Salk Institute. 
The process of wound healing requires serum factors 
[41,42). Migration factors that enable the cells to move into the 
wound in the absence of serum have been isolated, but the cells 
do not initiate DNA synthesis without the addition of serum or 
of other macromolecular-weight growth factors from serum 
[42). 
To initiate the cells in the monolayer surrounding the wound, 
one must increase the serum concentration or growth factor 
concentration in the medium. This greater serum requirement 
for the crowded cells in the monolayer is not fully understood, 
but it is known that polypeptide growth factors are neutralized 
or destroyed by cells [4]. As the cell density increases, the rate 
of destruction probably also increases, a phenomenon that may 
explain the higher serum requirement of crowded cells since 
destruction of the serum factors would lead to the existence of 
a diffusion boundary layer for the growth factors [43]. In 
addition, it is likely that the surface area and mobility of cells 
decrease as the cells become more crowded, and this crowding 
may cause them to be less responsive to a given concentration 
of growth factors . There is evidence that the surface area of 
cells is important in density-dependent regulation of growth 
[44-46]. 
EFFECT OF NUTRIENTS 
Manipulations of the culture medium have demonstrated 
that low concentrations of low-molecular-weight nutrients such 
as amino acids, glucose, or ions in the presence of normal 
concentrations of serum can lead to G-l arrest of the cell 
culture. One can then stimulate the cells to initiate growth and 
to proceed through the cell cycle by raising the concentration 
of the nutrients [47,48]. Dulbecco and Elkington were able to 
stimulate arrested BalblC 3T3 cells by increasing the Ca++ 
concentration above the normal level [49). These results indi-
cate that the growth of mammalian cells can be regulated by 
changes in the concentration of nutrients inside the cell. The 
function of high-molecular-weight growth factors in serum 
could be to increase the concentration of one or more nutrients 
inside the cell by changing the uptake of nutrients through 
interactions with the cell membrane. Alternatively, serum fac-
tors and nutrient concentrations may operate independently on 
a common regulatory mechanism. 
EARLY EVENTS AFTER STIMULATION 
Investigations into the stimulation of quiescent cultures have 
revealed a number of cellular changes occurring in response to 
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the addition of growth factors. Herschko et al [50] suggested 
the term "pleiotypic response" for these collective changes. The 
changes include the increases in the transport of nutrients and 
ions [48,50- 53], changes in RNA and protein synthesis [50, 
54,55], changes in the in~racellular concentrations of cyclic 
nucleotides [35,56,57], and the assembly of microtubules [58]. 
One of the earliest changes detected after growth stimulation 
is a decrease in the membrane potential as observed by Hiilser 
and Frank [59]. The membrane potential between the inside 
and outside of a mammalian cell mainly depends on differences 
in the intra- and extracellular concentrations of potassium ions 
as well as on the permeability of the plasma membrane to these 
ions. The Na+ - K+-activated ATPase maintains this membrane 
potential. The membrane potential of rat embryo fibroblasts 
was reported to decrease from -50 mv to a minimum of -17 
mv within 3 min after exposure to serum growth factors; after 
2 hr of incubation in the presence of growth factors, the mem-
brane potential was restored to its original value. D epolarization 
was not observed when inactive serum fractions were added to 
the cultures. There also was no change in the membrane 
potential of a transformed rat cell line that grew independently 
of serum [59]. 
Phosphatidyl inositol turnover is increased during the fU'st 
few minutes after fibroblasts arrested during G 1 have been 
stimulated by growth factors. * The specific activity of 32p_ 
phosphate in phosphatidyl inositol increases seven- to eightfold 
30 min after the addition of serum or growth factors, whereas 
the other phospholipids show no or only a slight increase in 
synthesis during this time. When rat embryo fibroblasts are 
prelabeled with 3H-inositol, up to 15 to 20% of the total radio-
activity is eliminated from the phospholipid fraction 20 to 40 
min after stimulation with serum. Within 1 to 2 hr the original 
value is restored. 
Among the early events, that receiving the most attention 
has been the changes in the intracellular concentration of cyclic 
nucleotides. Many investigators have reported a decrease in 
cAMP when resting fibroblasts are stimulated to grow [56, 
60, 61]' Decreased levels of cAMP have been reported for 
logarithmically growing cells and for transformed cells; re~~ing 
cells reportedly have high concentrat ions [61,62]. In additIon, 
dibutyryl-cAMP added to growing fibroblasts can reversibly 
inhibit DNA synthesis and growth [63] , as well as the uptake of 
uridine, leucine, and 2-deoxyglucose [61]. Synthesis of ph os ph a-
t idyl inositol decreases by 50% in the presence of dibutryl-
cAMP without a change in the main cellulru' phospholipid 
component, phosphatidylcholine [64]. Kram, Mamont, and 
Tomkins concluded that cAMP may act as a regulator of the 
"pleiotypic response" [61]. 
Reports from studies made with cultured lymphocytes [57] 
showed that although cAMP levels were unaltered after growth 
stimulation, the concentration of another cyclic nucleotide, 
cGMP, increased. It was suggested in 1973 that the ratio of 
cGMP to cAMP is important for the commitment of cells to 
the initiation of DNA synthesis. This model became popularly 
known as the "Yin-Yang" hypothesis [65]. Voorhees and co-
workers observed in rapidly dividing epidermis, e.g., psoriatic 
lesions, that the concentration of cAMP is decreased and that 
of cGMP is increased [66]. Shortly thereafter, Seifert and 
Rudland also observed an increase in cGMP and a decrease in 
cAMP after stimulation of fibroblasts [36]. Although all of these 
results favor the idea of cyclic nucleotides playing a regulatory 
role in growth control, there are other reports that do not . For 
example, other investigators have not observed an increase in 
cGMP in fibroblasts after stimulation [67]. It is also reported 
that in hepatocytes and lymphocytes, DNA synthesis is pre-
• Ristow H-J , Hoffmann R, Frank W, Paul D: Phospholipids with 
special emphasis on changes in phosphatidyl inosito l that accompany 
changes in cellular growth state, Symposium on Nutritional Require-
ments of Vertebrate Cells in Culture, Lake Placid 1975. Edited by P 
Chapple and RG Ham, to be published. 
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ceded by an increase instead of a decrease in cAMP [68,69]. 
These conflicting observations have created doubts concerning 
the importance of cyclic nucleotides in growth regulation. In 
addition, because cyclic nucleotides ru'e involved in many dif-
ferentiated functions of cells, it seems doubtful that they ru'e 
the main regulator of cell growth. 
The role that the "pleiotypic response" plays in the initiation 
of DNA synthesis is uncleru·. Because of the long lag time 
between addition of growth factors and initiation of DNA 
synthesis, it is reasonable to assume that a program of events 
is necessary for initiation. The events described above, along 
with changes in RNA and protein synthesis, seem to be a 
generalized response of cells to stimulation by serum or hor-
mones but these observations tell us little of the mechanism of cellula~ commitment to DNA synthesis. A recent report describ-
ing a positive pleiotypic response in an adrenal cell line under 
conditions that led to differentiation and inhibition of DNA 
synthesis [70] makes questionable the causal relationship be-
tween these early events and initiation. 
CHALONES 
A group of compounds, referred to as chalones, ru'e reported 
to inhibit cell growth. Chalones are cell-specific but not species-
specific, and their action is reversible. 
Houck, Weil, and Sharma obtained a fibroblast chalone from 
medium extracts of cultured human fibroblasts and from tissue 
extracts of fibroblasts [71]. These extracts were active only on 
fibroblasts and cells from a human osteosarcoma, and not 'on 
epidermal, lynlphocytic, or other types of cells [72]. The chalone 
molecules isolated from these extracts are trypsin-labile pro-
teins which form strong complexes with RNA. They have a 
molecular weight of less than 10,000 but more than 1,000 
daltons, are cationic, and contain mannose [73]. Because there 
appears to be no direct interaction between chalones and fibro-
blast mitogens, it is suggested that cellulru' proliferation is 
controlled by a competition between chalones and growth fac-
tors for cellular receptor sites [74]. . 
CONCLUSIONS 
We still do not know the mechanism of action of growth 
factors or, more importantly, the way in which a fibroblast 
becomes committed to initiate DNA synthesis. It does apperu' 
that many growth factors can stimulate fibroblasts and that 
these growth factors interact and are more active in combina-
tion than alone. It is likely that different factors act on different 
types of cells and that some larger molecules are only the 
cru'l'iers for the active smaller ones that ru'e not sepru'ated by 
the isolation procedure. Some factors may not be specific but 
may express growth activity through nonspecific interactions 
with cell sUlface receptors. Another possibility is that there 
exists a whole set of factors working together in a "cascade" as 
in the clotting, complement, or kinin systems. 
How a fibroblast chalone would fit into this system is unan-
swered. Although we do not have much information concerning 
a growth factor-chalone interrelationship in regulating growth, 
both may compete for the srune receptor site at the cell sW'face. 
We probably will have to wait until the molecule has been 
pW'ified before we can hope to understand its mechanism of 
action. 
The early events inside stin1Ulated cells tell us little about 
the way in which a cell is committed to the initiation of DNA 
synthesis. Except for the more general effects of increased RNA 
and protein synthesis, all the other events apperu' to be unn~c­
essary for initiation of DNA synthesis. They may be only Side 
effects, such as an expression of lysosomal activation to inter-
nalize and digest the foreign substances attached to the cell 
SUlface. 
The main question behind all t hese investigations is, "B:0w 
applicable to the in vivo situation ru'e these d~ta?" There eXlsts 
a large gap between oW' observations of tissue culture and 
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observations of normal tissues in s itu . Results from tissue 
culture studies give no explanation of why dividing fibroblasts 
in a wounded area in the organism are first observed after 2 
days [75] and why t h ese fibroblasts do not come from the 
surrounding dermis but rather from walls of adjacent blood 
vessels or nearby sarcolemma [76]. T h e idea of a growth factor 
released in large amounts from t h e injured blood vessels or of 
a chalone removed from the tissue d oes not fit in with this 
observation. The assumption th at cells su ch as macrophages, 
which precede fibroblasts into t h e wound area, may influence 
migration and division of fibroblasts is probably more compat-
ible w ith th e observed process of wound h ealing in vivo. It h as 
been reported t h at su bstances released from dying macrophages 
stimulate fibroblast activity, which results in fibrosis [77]. 
Alt h ough experimental work with cultured fibroblasts has 
h elped us to overcome th e difficulties a nd complications found 
in the intact organism and has provided us with a greatly 
increased understanding of growth regulation, it will be neces-
sary to fmd ways to bridge the gap back to the intact organism 
before we can obtain answers concerning regulation of fibroblast 
growth. 
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Announcement 
A meeting, entitled "Progress in Cutaneous Immunopathology," conducted under the auspices of the 
"Institut National de la Sante et de la Recherche Medicale" will be held October 27-28, 1978, in Lyon, 
France. 
The meeting will be conducted in English and French and will comprise 4 sections: (1) In vivo fixation 
and cytotoxicity of antibodies on skin diseases, (2) immune complexes and complemen t in skin disease, 
(3) surface markers and antigen s of the epidermal cells and cutaneous lymphoma cells, and (4) ch emotaxis 
and cutaneous diseases. 
For additional information, please write to : Professeur J . Thivolet, FRA INSERM N ° 11 "Recherche 
Dermatologique et Immunologie," Clinique Dermatologique, Hopital Edouard Herriot, 69376 Lyon Cedex 
2 (France). 
